Filter
991
Text search:
second-line
Featured
Recommendations
127
New Publications
321
Language
Document type
No document type
716
Guidelines
109
Studies & Reports
86
Manuals
33
Strategic & Response Plan
15
Fact sheets
14
Training Material
10
Situation Updates
5
Infographics
3
Countries / Regions
India
83
Western and Central Europe
41
Eastern Europe
30
Kenya
25
South Africa
25
Tanzania
24
Ethiopia
23
Nepal
22
Uganda
19
Malawi
18
Rwanda
13
Latin America and the Carribbean
13
Nigeria
12
Namibia
12
Global
12
Zambia
11
Myanmar / Burma
11
Ukraine
10
Africa
10
Cambodia
9
Bangladesh
9
Asia
9
Mozambique
8
Liberia
7
Philippines
7
Sierra Leone
6
Indonesia
6
Zimbabwe
5
Russia
5
Senegal
4
Cameroon
4
Ghana
4
Pakistan
4
Botswana
4
Lesotho
4
South–East Asia Region
4
Albania
4
Eswatini/ Swaziland
3
Tajikistan
3
Burkina Faso
2
Congo, Democratic Republic of
2
Haiti
2
Somalia
2
South Sudan
2
Thailand
2
Argentina
2
Brazil
2
Colombia
2
Bolivia
2
Yemen
2
East and Southern Africa
2
West and Central Africa
2
Armenia
2
Georgia
2
Jordan
1
Afghanistan
1
Lebanon
1
Syria
1
Gambia
1
China
1
Sudan
1
Peru
1
North Macedonia
1
Madagascar
1
Sri Lanka
1
Chile
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
Venezuela
1
Laos
1
Timor Leste/ East Timor
1
Vietnam
1
North America
1
Denmark
1
Authors & Publishers
Publication Years
Category
Countries
380
Clinical Guidelines
149
Women & Child Health
42
Public Health
33
Capacity Building
11
Pharmacy & Technologies
11
Key Resources
9
Toolboxes
TB
274
HIV
168
AMR
54
Mental Health
26
Pharmacy
24
NTDs
13
COVID-19
11
Caregiver
10
NCDs
10
Polio
9
Refugee
8
Rapid Response
6
Disability
5
Ebola
5
Conflict
5
Planetary Health
5
Cholera
3
Global Health Education
3
Health Financing Toolbox
3
Natural Hazards
2
Zika
1
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
Las personas infectadas por el virus de la inmunodeficiencia humana (VIH) tienen
29 veces más probabilidades de enfermar de tuberculosis (TB) que las personas
sin VIH que viven en el mismo país. La TB es una de las principales causas de muerte entre las personas infectadas por el VIH: provoca
...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i
...
As part of the UN’s data strategy—which seeks to nurture data as a strategic asset for insight, impact and integrity—UNAIDS plays an indispensable role in generating data for effective action against the AIDS pandemic. It leads the
world’s most extensive data collection on HIV epidemiology,
...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach
...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the
...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions
...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti
...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines
...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e
...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali
...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im
...
This guide presents a basis for understanding how diarrhoeal diseases are currently influenced by climate and weather, and may be further exacerbated by climate change. It is a technical guide on how to conduct a Vulnerability & Adaptation assessment for diarrhoeal diseases and climate change, and p
...
What countries need: Investments needed for 2010 targets
South Sudan continues to struggle with a severe health crisis affecting 8.9 million people, primarily in flood- and conflict-affected regions with population movements (displacement and returns), and disease outbreaks. The nation's health system, heavily reliant on international aid, faces staffing
...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome
...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a
...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc
...
